Prevalence, Predictors, and Impact of Conservative Medical Management for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Have Angiographically Documented Significant Coronary Disease
Mark Y. Chan, MD, MHS*,
Kenneth W. Mahaffey, MD, FACC*,
Lena J. Sun, MS*,
Karen S. Pieper, MS*,
Harvey D. White, MD, FACC ,
Philip E. Aylward, MD, FACC ,
James J. Ferguson, MD, FACC ,
Robert M. Califf, MD, FACC*,
Matthew T. Roe, MD, MHS, FACC*,*
* Duke Clinical Research Institute, Durham, North Carolina
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
Flinders Medical Center, Adelaide, Australia
Texas Heart Institute, St. Luke's-Episcopal Hospital, Houston, Texas.
View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Late or Repeat Revascularization
*Discharge landmark time point of discharge, or 7 days if hospitalization was prolonged; Includes re-exploration. Abbreviations as in Figure 1.
|
|
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3 In-Hospital and Post-Discharge Mortality
(A) Death from catheterization through discharge. (B) Death from discharge* through 1 year. Log-rank p values: conservative medical management versus PCI, p < 0.0001; conservative medical management versus CABG, p = 0.08. *Landmark time point of discharge, or 7 days if hospitalization was prolonged. Abbreviations as in Figure 1.
|
|
|
